INTRODUCTION
An increase in mortality from asthma occurred in the mid1960s in New Zealand, Australia, England, and Wales 1). It had increased from the latter half of the 1970s in many countries 2"7, especially in the 5-34 year-olds 2" 5, ". It was reported that the medications for asthma brought changes in asthmatic mortality a s).
Although the reported prevalence of this disease increased in various countries and age groups 10-18), the relationship between asthma morbidity and mortality has not been examined in detail. Only a few studies reported the case-fatality 19) and mortality/morbidity ratios 20). In other words, it is still unclear whether the change in mortality was due to the increase in morbidity, a rise in fatalities, or both. The purpose of this study is to determine whether the increase in the prevalence has influenced its mortality in Japan.
METHODS
Mortality, prevalence, and fatalities in asthma were calculated from data obtained from Patient Survey and Vital Statistics of Japan after 1984, when the current survey methods were adopted.
From Vital Statistics of Japan between 1984 and 1996, agespecific asthmatic mortality was calculated every 3 years. The patients were assigned to age groups: 0-9, 10-24, 25-44, 45-64, 65-74, and 75+ years. During the years specified above, asthma was classified according to the International Classification of Diseases (ICD) 493 (ICD 9th, 1984 (ICD 9th, -1994 , and J43 and J44 (ICD 10th, 1995 (ICD 10th, -1996 .
To study the trends in prevalence, the total number of patients receiving medical treatment for asthma estimated in Patient Survey was divided by age and sex. The total numbers of patients with the disease, including those out-patients who had not visited a hospital or clinic on the survey day, were obtained, classifying them by age and sex. The total number of asthmatic patients was computed by using the following formula 21): The number of asthmatic patients = number of inpatients on the survey day + number of out-patients (those visiting a facility for the first time) + number of out-patients (making a return visit on the survey day) x average time from the last visit x adjusting index (6/7)
A fatality has been defined as the death rate observed when a designated series of persons affected by an event 22). In this study, an asthmatic fatality is expressed as the number of deaths from asthma in one year per 100,000 asthmatic patients receiving medical treatment on the survey day.
RESULTS
The age-and sex-specific mortalities in Japan are shown in Table 1 . For all age groups, the mortality among males was higher than among females during the periods of the study. For both sexes, the mortality of the 75+ group was the highest. Among males in the 10-24 and 25-44 groups it increased slightly while for those in the other age groups, it decreased during the same period. Among females, the mortality for the 10-24 and 25-44 groups increased, starting in 1984. It peaked in 1990. For the other age groups, downward trends were observed as in males.
The age-and sex-specific prevalence of asthma is shown in Table 2 . The prevalence in the 0-9 group was the highest of all age groups for every year during the survey period. Except for the 25-44 group, the prevalence among males was higher than for females. The prevalence showed increasing trends in all groups when classified by age and sex. The prevalence for the 0-9 group in 1996 was about twice what it was in 1987.
The asthma fatalities for males are shown in Figure Asthma fatalities for females are shown in Figure 2 . In the 0-9 group, 45 asthma deaths were counted per one hundred thousand asthma patients per year in 1984. Asthmatic fatalities increased by age as in males. For the 75+ group, 7,240 asthmatic deaths were counted per 100,000 asthma patients per year. Except for the 0-9 group, asthmatic fatalities for females were lower than for their male counterparts during the study period.
For the 0-9 and 65-74 groups, asthmatic fatalities decreased continually during the observation periods. Although it was not constant, the rates for the 45-64 and 75+ groups decreased from 1987 to 1996. For the 25-44 group, the rate peaked in 1987, then it began to decrease. For the 10-24 group, the rate Table 1 . The age-and sex-specific mortality rate of asthma in Japan.
(/1 00,000 population/year) groups widened each year; however, it was smaller than that for males during the study period.
DISCUSSION
The major index used in this study, asthma fatality, is defined as the number of deaths from asthma in one year per 100,000 asthmatic patients under medical treatment. It should be noted that "fatality" in this study is defined as that with its numerator determined by the number of asthmatic death for that year. It is impossible to distinguish the factors associated It has been reported that among elderly persons, the true asthma mortalities were overestimated 23, 24) . It is often difficult to distinguish between asthma and other obstructive respiratory diseases with asthma-like symptoms, especially in the very young and the elderly 23.25). Death certificates may be inaccurate, the degree of inaccuracy being greater for the elderly,24 children, and young adults 26). For the 5-45 group, it is generally accepted that the diagnosis of asthma is reasonably reliable 27.28)
In the current study, asthma mortality for the 10-24 and 25-44 groups increased during the survey period. Similar trends were observed in these age groups in many countries 2-5.7). It can be inferred that the different trends in asthma mortality in these age groups were not simply due to the difference in clinical diagnoses or characteristics of the age. This may be one of the causes for the increase in the preval ence of asthma.
The reported prevalence of asthma increased in various c ountries and age groups 10-18) The changes in diagnostic modalities, together with an increased frequency of detection, m ay have contributed to the upward trends in the prevalence of asthma 4,10). In Japan, advances in laboratory test methods may have changed the diagnostic criteria and increased the number of reported cases of allergic rhinitis32). However, the observed increase in asthma was not simply due to an increased awareness of asthma, reporting and labeling bias because it has been reported that the prevalence of asthma had increased anyway, even when the same diagnostic criteria were used during the study periods 12, 14) .
Asthma fatalities decreased after 1990 for all age groups in this study. In Canada, mortality/morbidity ratios were observed between 1971 and 1983. The trends showed a peak in the middle of this period 20). Among hospitalized US veterans, asthma fatalities declined between 1970 and 1987 19). This may have been due to changes in the severity of asthma 33), improved treatments, and birth cohort-related changes in smoking exposure 3, 19) .
There is a possibility that risk factors for asthmatic deaths are associated with age because asthma mortality increased only in the 10-24 and 25-44 groups, although the prevalence of asthma increased among all groups when classified by age and sex. It was reported that inhaled fenoterol increases the risk of death in patients with severe asthma in the 5-45 group 34; and that the sale of specific types of anti-asthma medications was related to the trends in asthma mortality 8,9). The observed decrease in asthma fatalities implies that the influence of anti-asthma treatment on asthma mortality is moderated and coincidental with the decrease in mortality and the sale of fenoterol in New Zealand 8). In Japan, asthma mortality closely paralleled the change in the sale of 2-agonist metered dose inhalers during 1950 and 1993 . One should be cautious in interpreting the different trends in age-specific asthma mortality. Further research will be required to determine the reasons for these different trends in mortality and fatalities by age.
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